Vendis Capital Management
Key facts
Recent exits
No exits recorded yet.
Coverage notes
0 funds tracked, 0 portfolio companies (0 active · 0 realized). Verified weekly from public filings and deal announcements.
About Vendis Capital Management
Vendis Capital Management, operating under the brand Vendis, is an independent consumer-focused private equity firm founded in 2009 and headquartered in Diegem in the Brussels metropolitan area, Belgium, with team presence in the German and Dutch markets. Vendis has raised more than €1.1 billion of capital across its fund family and runs four fund generations, Vendis Capital I through IV, with Vendis Capital IV reaching a €525 million hard cap at final close in March 2025. Assets under management are on the order of €800 million-plus of active capital as of December 2024. The firm's track record spans more than 50 historical investments and around 25 years of consumer brand-building experience, with Vendis IV classified as an Article 8 fund under EU sustainable-finance regulation.
Investment thesis
Vendis Capital pursues lower-mid-market private equity dedicated to consumer-facing businesses, backing small and medium-sized consumer scale-ups and brands. Sector focus spans beauty and cosmetics, food and beverage, health and wellness, home and garden, pet care, sports and leisure, and consumer retail. Geography centres on the Netherlands, France, the DACH region, Belgium and the Nordics. The limited partner base is a mix of institutional investors, family offices and high-net-worth individuals. Value creation is hands-on: Vendis partners with founders and management teams and applies a structured growth framework, driving international expansion, digitalisation, new-channel and category growth, and organic plus buy-and-build M&A to turn companies into iconic brands.
Recent activity
Recent investments include Nederlandse Obesitas Kliniek in outpatient healthcare and obesity clinics (2025), alongside consumer brands across cosmetics, food and pet care deployed through Vendis Capital IV. Recent exits include BitterLiebe in consumer health and supplements (2024) and Alpine Hearing Protection in consumer products and hearing protection (2025). The platform continues to deploy lower-mid-market capital across European consumer-facing businesses. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.